Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of drugs in China. The company offers drugs for oncology indications,...
CEC Capital advises Zhongkexinyang on 100-million-yuan private financing round
REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-Rez
Shouyao Holdings: RET inhibitor Sotorasib tablets (SY-5007) new drug application has been accepted
Zhitong A-share lock-up release overview | September 23
Shouyao Holdings: Net profit loss of 104 million yuan in the first half of 2025
The three major A-share indices of the Shanghai and Shenzhen markets rose by 0.6% to 2.8% in the first half of the day, with brokerage and innovative drug concept stocks gaining